Position
Renaissance Technologies in Champions Oncology, Inc.
Back to the book · All holders of CSBR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $57K$5.75 → $6.16
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 154.8K | $1.07M | — | — | — | 0.0% |
| Q1 2026 | 145.5K | $836.8K | $5.75 | −$168.8K | −$64.3K | 0.0% |
| Q2 2026 | 139K | $856.5K | $6.16 | $57K | −$37.4K | 0.0% |